Abstract
Many efforts are currently being made to connect small molecules to target proteins by extracting pharmacological data from bibliographic sources and storing them in annotated chemical libraries. Here, small molecules are further connected to biological pathways, with particular focus to pathways involving members of the nuclear receptor family. The results bring to light the relative importance for molecules on gaining selectivity at the target level, when the target has an intrinsic promiscuity at the pathway level, and highlight the implications for drug discovery to address current challenges related to poor drug efficacy and toxicity. Details on the main limitations encountered during the molecule-to-target-to-pathway annotation process are also discussed.
Keywords: Wnt signaling pathway, retinoic X receptor, farnesoid X receptor, lipid metabolism, CYP7A1 inhibition
Current Topics in Medicinal Chemistry
Title: Connecting Small Molecules to Nuclear Receptor Pathways
Volume: 7 Issue: 15
Author(s): Kristina Hettne, Montserrat Cases, Scott Boyer and Jordi Mestres
Affiliation:
Keywords: Wnt signaling pathway, retinoic X receptor, farnesoid X receptor, lipid metabolism, CYP7A1 inhibition
Abstract: Many efforts are currently being made to connect small molecules to target proteins by extracting pharmacological data from bibliographic sources and storing them in annotated chemical libraries. Here, small molecules are further connected to biological pathways, with particular focus to pathways involving members of the nuclear receptor family. The results bring to light the relative importance for molecules on gaining selectivity at the target level, when the target has an intrinsic promiscuity at the pathway level, and highlight the implications for drug discovery to address current challenges related to poor drug efficacy and toxicity. Details on the main limitations encountered during the molecule-to-target-to-pathway annotation process are also discussed.
Export Options
About this article
Cite this article as:
Hettne Kristina, Cases Montserrat, Boyer Scott and Mestres Jordi, Connecting Small Molecules to Nuclear Receptor Pathways, Current Topics in Medicinal Chemistry 2007; 7(15) . https://dx.doi.org/10.2174/156802607782194671
DOI https://dx.doi.org/10.2174/156802607782194671 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment
Current Drug Targets MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
Current Drug Targets Potential Gene Therapy Strategies for Cancer Stem Cells
Current Gene Therapy Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design A Preliminary Study of the Action of Virtosomes from Non-dividing Cells on Tumour Cell Replication in vitro and in vivo
Anti-Cancer Agents in Medicinal Chemistry MicroRNA-34b Inhibits Pancreatic Cancer Metastasis Through Repressing Smad3
Current Molecular Medicine Potential Anti-cancer Drugs Commonly Used for Other Indications
Current Cancer Drug Targets Targeting Gene Therapy for Prostate Cancer
Current Pharmaceutical Design Drug Loaded Erythrocytes: As Novel Drug Delivery System
Current Pharmaceutical Design New Molecules and Strategies in the Field of Anticancer Agents
Current Medicinal Chemistry - Anti-Cancer Agents Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis
Current HIV Research Local Gene Delivery for Cancer Therapy
Current Gene Therapy Current Bioactive Azole-Containing Natural Products
Current Bioactive Compounds Cratylia mollis Lectin: A Versatile Tool for Biomedical Studies
Current Bioactive Compounds Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
Current Pharmaceutical Design Applications of Muscle Electroporation Gene Therapy
Current Gene Therapy Tumor Necrosis Factor-α-Mediated Pulmonary Endothelial Barrier Dysfunction
Current Respiratory Medicine Reviews Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Protein & Peptide Letters Involvement of Cysteine Proteases in Cancer
Current Medicinal Chemistry